NDC 0143-9976-91 - Cefuroxime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9976
- Requested NDC
- 0143-9976-91
- Package NDCs from labels
- 0143-9976-91, 0143-9976-03
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2020-04-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefuroxime - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2020-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9976-03 | Cefuroxime | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 8 | |
| 0143-9976-91 | Cefuroxime | 82.5 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, POWDER, FOR SOLUTION | 82.5 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9976-03 | EA - Each | 0143-9976 | 510e4821-e594-4557-95fe-f40c80c4508e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFUROXIME SODIUM | ACTIVE INGREDIENT | R8A7M9MY61 | CEFUROXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| CEFUROXIME | ACTIVE MOIETY | O1R9FJ93ED | CEFUROXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefuroxime sodium | CEFUROXIME SODIUM | Sagent Pharmaceuticals | 0a145288-733a-4966-b7ae-dc96eb103d8c | 2025-03-27 | Warnings, Adverse reactions | R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 79f5cf6f-a5e2-49a2-9704-fa1bd21338c3 | 2022-02-16 | Warnings, Adverse reactions | ANDA065046 309101 R8A7M9MY61 |
| Cefuroxime and Dextrose | CEFUROXIME AND DEXTROSE | B. Braun Medical Inc. | 07170ee3-1a24-424f-a2a2-00bc92e98f85 | 2020-12-05 | Warnings, Adverse reactions | R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 65daa2aa-cc4a-4eba-b7dc-7a151806865a | 2020-04-14 | Warnings, Adverse reactions | ANDA065046 0143-9976-91 0143-9976-03 0143-9976 00143997691 309101 5621cde0-74c5-45b2-8f76-329eb22b4a0a 65daa2aa-cc4a-4eba-b7dc-7a151806865a R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 703cc338-c0b6-4a02-b8db-c27aeff181df | 2020-04-08 | Warnings, Adverse reactions | R8A7M9MY61 |
| Cefuroxime | CEFUROXIME | Hikma Pharmaceuticals USA Inc. | 19902965-d2d6-433f-982d-0095014df4e8 | 2018-09-27 | Warnings, Adverse reactions | R8A7M9MY61 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.